Medicare Enrolled
Dr. Isaac Tawfik, MD
Interventional Cardiology · Eatontown, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tawfik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tawfik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tawfik
Dr. Isaac Tawfik is an interventional cardiology specialist in Eatontown, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tawfik performed 5,956 Medicare services across 4,097 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tawfik received a total of $23,869 from 60 pharmaceutical and/or device companies across 581 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tawfik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in NJ
$23,869 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,956
Medicare services
Top 16% in NJ for interventional cardiology
4,097
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~313 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,385 | $6 | $46 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
954 | $98 | $834 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
784 | $11 | $99 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
361 | $65 | $485 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
325 | $158 | $854 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
271 | $104 | $564 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $43 | $502 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
177 | $88 | $697 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
130 | $159 | $1,338 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
120 | $104 | $849 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
116 | $1,504 | $8,866 |
| Ultrasound-guided injection into multiple incompetent leg veins A procedure where a chemical agent is injected into several faulty veins in the same leg. Ultrasound guidance is used to ensure accurate placement of the injection. |
95 | $1,269 | $7,827 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
90 | $160 | $1,309 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $129 | $1,082 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
83 | $50 | $479 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
76 | $94 | $433 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
70 | $380 | $3,077 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
67 | $473 | $624 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
53 | $111 | $863 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $77 | $400 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
50 | $10 | $346 |
| Cardiac catheterization | 43 | $217 | $1,835 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
38 | $17 | $136 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
38 | $11 | $90 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
31 | $45 | $387 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
31 | $99 | $954 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
30 | $32 | $261 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $148 | $1,187 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
28 | $64 | $600 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
28 | $32 | $275 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
24 | $25 | $195 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
21 | $20 | $162 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
19 | $11 | $86 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
19 | $13 | $151 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
19 | $211 | $1,403 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $127 | $1,240 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
12 | $154 | $1,223 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
24.4% medium
71.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,869
Total received (2018-2024)
Avg $3,410/year across 7 years
Top 20% in NJ for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
581
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,432 (64.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,436 (35.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,050
2023
$2,820
2022
$2,303
2021
$1,461
2020
$1,026
2019
$11,334
2018
$2,874
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$192
Novartis Pharmaceuticals Corporation
$164
Actelion Pharmaceuticals US, Inc.
$151
Alnylam Pharmaceuticals Inc.
$137
iRhythm Technologies, Inc.
$131
CVRx, Inc.
$129
Boston Scientific Corporation
$128
Amgen Inc.
$118
Penumbra, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
Kestra Medical Technology Services, Inc.
$73
Merck Sharp & Dohme LLC
$70
PFIZER INC.
$63
E.R. Squibb & Sons, L.L.C.
$57
Janssen Pharmaceuticals, Inc
$55
ABIOMED
$44
Novo Nordisk Inc
$42
SCPHARMACEUTICALS INC.
$35
United Therapeutics Corporation
$34
Philips North America LLC
$29
Acist Medical Systems, Inc.
$29
AstraZeneca Pharmaceuticals LP
$28
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
AGEPHA Pharma FZ LLC
$20
Bard Peripheral Vascular, Inc.
$19
Regeneron Healthcare Solutions, Inc.
$18
Silk Road Medical, Inc.
$17
Biogen, Inc.
$17
Kiniksa Pharmaceuticals International, plc
$17
Top 3 companies account for 24.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$8,798
Abbott Laboratories
$3,457
Philips Electronics North America Corporation
$1,660
Janssen Pharmaceuticals, Inc
$901
iRhythm Technologies, Inc.
$824
AstraZeneca Pharmaceuticals LP
$804
Actelion Pharmaceuticals US, Inc.
$530
Amgen Inc.
$518
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$491
Boehringer Ingelheim Pharmaceuticals, Inc.
$479
Boston Scientific Corporation
$426
E.R. Squibb & Sons, L.L.C.
$396
BARD PERIPHERAL VASCULAR, INC.
$391
Cardiovascular Systems Inc.
$305
Medtronic, Inc.
$303
PFIZER INC.
$294
Merck Sharp & Dohme LLC
$274
CVRx, Inc.
$232
Medtronic Vascular, Inc.
$220
Acist Medical Systems, Inc.
$170
Amarin Pharma Inc.
$163
Bayer HealthCare Pharmaceuticals Inc.
$154
Novo Nordisk Inc
$141
Alnylam Pharmaceuticals Inc.
$137
ARBOR PHARMACEUTICALS, INC.
$134
Merck Sharp & Dohme Corporation
$121
Penumbra, Inc.
$110
Regeneron Healthcare Solutions, Inc.
$107
ABIOMED
$90
Gilead Sciences, Inc.
$86
BOSTON SCIENTIFIC CORPORATION
$80
Biocompatibles, Inc.
$78
Silk Road Medical, Inc.
$78
Kestra Medical Technology Services, Inc.
$73
Kiniksa Pharmaceuticals, Ltd.
$71
Kowa Pharmaceuticals America, Inc.
$69
W. L. Gore & Associates, Inc.
$66
SANOFI-AVENTIS U.S. LLC
$56
Esperion Therapeutics, Inc.
$42
AngioDynamics, Inc.
$39
Akcea Therapeutics, Inc.
$37
SCPHARMACEUTICALS INC.
$35
United Therapeutics Corporation
$34
Misonix Inc
$34
Daiichi Sankyo Inc.
$32
Bardy Diagnostics, Inc.
$30
Philips North America LLC
$29
PORTOLA PHARMACEUTICALS, INC.
$28
Lundbeck LLC
$27
GENZYME CORPORATION
$27
CashFlow Solutions, LLC
$26
Sensible Medical Innovations Inc
$23
AGEPHA Pharma FZ LLC
$20
Bard Peripheral Vascular, Inc.
$19
Biogen, Inc.
$17
Kiniksa Pharmaceuticals International, plc
$17
ShockWave Medical, Inc
$17
Tactile Systems Technology Inc
$16
Impulse Dynamics (USA) Inc.
$15
Cardinal Health 200, LLC
$15
Top 3 companies account for 58.3% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (9281) Turbo Elite · ABRE · ACCENT · AMVUTTRA · ANDEXXA · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Adempas · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BEVYXXA · BRILINTA · Barostim Neo System · Bidil · BoneScalpel · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · CONFIRM RX · CVI Consumables · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · Corlanor · Diamondback Peripheral · EKOSONIC · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EVKEEZA · Edarbi · FABRAZYME · FARXIGA · FASENRA · FLEXITOUCH · FUROSCIX · GORE CARDIOFORM Septal Occluder · IGT D Peripheral · INJECTAFER · Impella · Indigo System · Intracardiac Echocardiography (ICE) · JARDIANCE · JETI · Kerendia · LEQVIO · LINQ II · LODOCO · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LYMPHA PRESS OPTIMAL PLUS(US) BT · LYNPARZA · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · MynxGrip Vascular Closure Device · NEXLETOL · NORTHERA · ONYX FRONTIER · OPSUMIT · OPTIMIZER · Occluders · Ozempic · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · RXi Consumables · ReDS system · Repatha · Resolute · Reveal LINQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SKYCLARYS · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · UPTRAVI · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Venclose Maven Catheter · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
44
Per 100K population
6.8
County median income
$122,727
Nearest hospital
RIVERVIEW MEDICAL CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tawfik is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NJ), with low-engagement industry engagement in the top 20% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tawfik experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Tawfik performed 1,385 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tawfik receive payments from pharmaceutical companies?
Yes. Dr. Tawfik received a total of $23,869 from 60 companies across 581 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tawfik's costs compare to other interventional cardiologists in Eatontown?
Dr. Tawfik's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tawfik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Eatontown
Browse interventional cardiologists in Eatontown ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NJ
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NJ
Which NJ interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology